Atridia Pty Ltd.
Clinical trials sponsored by Atridia Pty Ltd., explained in plain language.
-
New hope for breast cancer: experimental combo enters human trials
Disease control Recruiting nowThis early-stage trial tests a new drug called HRS-6209 combined with standard hormone therapies (fulvestrant or letrozole) in people with a certain type of advanced breast cancer (HR-positive/HER2-negative). The main goal is to check safety and find the right dose. About 15 part…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New pill for chronic hives enters first human tests
Disease control Recruiting nowThis early-stage trial tests a single oral dose of HRS-3095, a new drug for chronic spontaneous urticaria (chronic hives), in 36 healthy adults. The main goal is to check safety and how the drug moves through the body. Results will guide future studies in patients with hives.
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New pill HRS-5041 tested in men with Tough-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called HRS-5041 in 25 men with metastatic castration-resistant prostate cancer, a form of prostate cancer that has spread and no longer responds to standard hormone therapy. The main goal is to check the drug's safety and how…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC